0001519749-21-000011.txt : 20210921
0001519749-21-000011.hdr.sgml : 20210921
20210921181842
ACCESSION NUMBER: 0001519749-21-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210917
FILED AS OF DATE: 20210921
DATE AS OF CHANGE: 20210921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hart Jayne B.
CENTRAL INDEX KEY: 0001519749
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 211267460
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-09-17
0
0000899923
MYRIAD GENETICS INC
MYGN
0001519749
Hart Jayne B.
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
Chief People Officer
Common Stock
2021-09-17
4
M
0
73225
26.49
A
153287
D
Common Stock
2021-09-17
4
S
0
64480
33.72
D
88807
D
Common Stock
2021-09-17
4
M
0
3775
26.49
A
92582
D
Common Stock
2021-09-17
4
S
0
2966
33.72
D
89616
D
Incentive Stock Option (right to buy)
26.49
2021-09-17
4
M
0
3775
0.0
D
2021-09-17
Common Stock
3775
0
D
Non-Qualified Stock Option (right to buy)
26.49
2021-09-17
4
M
0
73225
0.0
D
2021-09-17
Common Stock
73225
0
D
Represents the net exercise of outstanding stock options. The reporting person received 8,745 shares of common stock on net exercise of options to purchase 73,225 shares of common stock. The company withheld 64,480 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.
Represents the net exercise of outstanding stock options. The reporting person received 809 shares of common stock on net exercise of options to purchase 3,775 shares of common stock. The company withheld 2,966 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.
The shares subject to this option are fully vested and exercisable.
By: Nathan A. Smith For: Jayne B. Hart
2021-09-21